Taiyo Pharma Research & Development Private Limited
About Taiyo Pharma Research & Development Private Limited
Data last updated:
Taiyo Pharma Research & Development Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 26 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2021PTC372331.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chrisann Sequeira and Kunal Vijay Bhatt.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C – 2012A Kailash Business Park Vikhroli (W) Park Side Road, Mumbai, Maharashtra, India – 400079.
Company details
Contact details
Taiyo Pharma Research & Development Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressC – 2012A Kailash Business Park Vikhroli (W) Park Side Road, Mumbai, Maharashtra, India – 400079
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Taiyo Pharma Research & Development Private Limited
FY 2022 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Taiyo Pharma Research & Development Private Limited, buy the company report.
Board of directors of Taiyo Pharma Research & Development Private Limited
Taiyo Pharma Research & Development has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chrisann Sequeira | Director | 26 Nov 2021 | 4 Years 11 Months | Current |
| Kunal Vijay Bhatt | Director | 26 Nov 2021 | 4 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Taiyo Pharma Research & Development Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Taiyo Pharma Research & Development Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Taiyo Pharma Research & Development Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Taiyo Pharma Research & Development Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Arjun Sanjay Patel ceased to be Director on 19 May 2023.
Frequently asked questions
Taiyo Pharma Research & Development is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 26 November 2021 (5+ years old) and is registered under CIN U24230MH2021PTC372331.
Taiyo Pharma Research & Development has 2 current directors:
- Chrisann Sequeira - Director
- Kunal Vijay Bhatt - Director
The latest financial statements of Taiyo Pharma Research & Development on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Taiyo Pharma Research & Development is U24230MH2021PTC372331. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Taiyo Pharma Research & Development was incorporated on 26 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Arjun Sanjay Patel ceased to be Director on 19 May 2023. Jesal Parag Thakkar ceased to be Director on 05 Mar 2022. Chrisann Sequeira was appointed as Director on 26 Nov 2021. Taiyo Pharma Research & Development has 4 board changes on record in total.
The registered office of Taiyo Pharma Research & Development is at C – 2012A Kailash Business Park Vikhroli W Park Side Road, Mumbai, Maharashtra, India – 400079.
Taiyo Pharma Research & Development operates in the chemicals industry, in the manufacturing segment.
Taiyo Pharma Research & Development can be reached at its registered office: C – 2012A Kailash Business Park Vikhroli W Park Side Road, Mumbai, Maharashtra, India – 400079.
Taiyo Pharma Research & Development is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
